期刊文献+

唑来膦酸同步放疗对恶性肿瘤骨转移止痛效果观察 被引量:10

下载PDF
导出
摘要 1 资料与方法 1.1 临床资料 选择2006年7月~2009年12月在我院治疗中的恶性肿瘤骨转移病人,其中前列腺癌并发骨转移11例,肺癌并发骨转移19例,乳腺癌并发骨转移12例,甲状腺癌并发骨转移4例,肾癌并发骨转移2例,共计48例.所有病人全部取得原发病灶病理明确诊断,并且"CT"、"MRI"及全身骨"ECT"等检查明确诊断骨转移发生部位,并且主诉骨转移部位剧烈疼痛的病例,其中男性:29例,女性:19例.
出处 《中国医药导刊》 2011年第2期336-336,共1页 Chinese Journal of Medicinal Guide
  • 相关文献

参考文献1

二级参考文献9

  • 1Conte P, Coleman R. Bisphosphonates ha the treatment of skeletal metastases[J]. Semin Oncol, 2004, 31(5 Suppl 10): 59~63.
  • 2Cameron D. Proven efficacy of zoledron acid in the treatment of bone metastases in patients with breast cancer and other malignancies[J]. Breast, 2003, 12 Supple 2:S22~S29.
  • 3Coleman RE, Seaman JJ. The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases [J]. Semin Oncol. 2001, 28(2 Suppl 6): 11~16.
  • 4Quint LE, Tummala S, Brisson LJ. et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer[J]. Ann Thorac Surg, 1996, 62(1): 246~250.
  • 5Coleman RE. Bisphosphonates: clinical experience [J]. Oncologist, 2004, 9 Suppl 4:14~27.
  • 6Berenson JR, Rosen LS, Howell A. et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases [J]. Cancer, 2001, 91(7): 1191~1200.
  • 7Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the trealanent of hypercalcemia of malignancy: apooled analysis of two randomized, controlled clinical trials [J]. J Clin Oncol,2001, 19(2): 558~567.
  • 8Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolyfic lesions of multiple myeloma: a phase Ⅲ, double-blind, comparative trial[J]. Cancer J, 2001, 7(5): 377~387.
  • 9Chang JT, Green L, Beitz J. Renal failure with the use of zoledronic acid[J]. N Engl J Med, 2003, 349(17): 1676~1679.

共引文献8

同被引文献99

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部